Nikolaos G Papadopoulos is an expert in Immunology at National and Kapodistrian University of Athens (Greece). As of October 2026, ScienceLeadR ranks Nikolaos G Papadopoulos in the top 1% of experts worldwide for Hypersensitivity and Asthma. Nikolaos G Papadopoulos has authored 917 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 2,367 (community average: 125). How the SLR is computed.

LeadR Profile

2 367 ScienceLeadR Reputation 2367
Network Map

Immunology

Subspecialties: Pulmonology - Pediatrics - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2006 - 2026

Source: PubMed

University of Manchester

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 917

Citations

Citations: 44 566 1st author: 96 Last author: 156 Unique author: 5


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
As-Needed Versus Regular Medication Use in the Treatment of Allergic Rhinitis in the Pollen Season: A MASK-air Study.
PMID 42714136 — histamine antagonists, rhinitis, allergic, hypersensitivity, masks, air, rhinitis, therapeutics
Allergy20260
Severity of Reactions in Double-Blind Placebo-Controlled Food Challenges: New Insights From the EuroPrevall Outpatient Clinic Study.
PMID 42663073 — safety, dermatitis, hypersensitivity, ambulatory care facilities, anaphylaxis, ovum, food, immunity, outpatients
J Investig Allergol Clin Immunol20260
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.
PMID 42638984 — therapeutics, asthma
J Asthma Allergy20260
ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases.
PMID 42613592 — change management, intelligence, chronic disease, air, rhinitis, asthma, artificial intelligence
Clin Transl Allergy20260
Efficacy and safety of oral treatments for allergic rhinitis in children: A network meta-analysis.
PMID 42596864 — quality of life, histamine antagonists, safety, receptors, leukotriene, rhinitis, allergic, hypersensitivity, signs and symptoms, drug-related side effects and adverse reactions, immune system diseases, network meta-analysis, leukotrienes, rhinitis, therapeutics, child, leukotriene antagonists
Pediatr Allergy Immunol20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 1

By phase:

N/A 3
Phase 3 2
Phase 4 1

By status:

Completed 4
Not yet recruiting 1
Unknown 1

By type:

Interventional 3
Observational 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
The Impact of Synergies of Indoor Air Pollutants on Childhood Health and Wellbeing
NCT05105386 — environmental exposure, environmental pollutants, air, environmental pollution, air pollutants, asthma, child
N/ANot yet recruiting2023

LeadR Networks

Main global connection map